NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

🇩🇰 The Danish Dude 🇬🇱
@FlemmingBruce
$NWBO

Do MHRA approve applications during Christmas?

What MHRA’s own December 2024 lists show

MHRA publishes two official lists for December 2024: one covering 1-14 December and one covering 15-31 December.

Count for December 2024

Using the MHRA lists and counting distinct PL numbers (each line item authorisation on those lists), December 2024 contains:

• 52 authorisations in 1-14 Dec
• 52 authorisations in 15-31 Dec
• Total: 104 authorisations across the month

Do approvals happen in the last two weeks of December?

Yes. The 15-31 December list includes approvals dated 23 Dec, 24 Dec, 27 Dec, 30 Dec, and 31 Dec.

Here are examples that look like “new branded medicines” rather than routine generics:

• LUMYKRAS (sotorasib) approved 16/12/2024
• WINREVAIR (sotatercept) approved 27/12/2024
• BIMERVAX XBB.1.16 (COVID-19 vaccine, recombinant, adjuvanted) approved 27/12/2024
• IMDYLLTRA (tarlatamab) approved 31/12/2024

So, from MHRA’s own publication record, end-of-year timing does not block approvals.

DCVax-L is typically discussed as an advanced therapy / cell-based product class.

The December 2024 lists show approvals including biologics and vaccines (f.eks. ustekinumab products, bevacizumab, COVID vaccine), plus oncology drugs.

For an investor inference:

• Strong support: MHRA signs approvals throughout late December, including on 31 Dec.

Yes, approvals for new medicines occur in the last two weeks of December, including 31 December, so “still possible” is consistent with MHRA’s observed approval timing.

8:32 PM · Dec 15, 2025
·
1,751
Views

$NWBO

Do MHRA approve applications during Christmas?

What MHRA’s own December 2024 lists show

MHRA publishes two official lists for December 2024: one covering 1-14 December and one covering 15-31 December.

Count for December 2024

Using the MHRA lists and counting distinct… pic.twitter.com/cysMSZuPdl

— 🇩🇰 The Danish Dude 🇬🇱 (@FlemmingBruce) December 15, 2025